1Barzilay JI,Abraham L,Heckbert SR,et al.The relation of markers of inflammation to the development of glucose disorders in the elderly:the Cardiovascular Health Study.Diabetes,2001 50(10):2384～2389.
2Freeman DJ,Norrie J,Caslake MJ,et al.C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.Diabetes,2002,51(5):1596～600.
3Guerrero-Romero F,Rodriguez-Moran M.Relation of C-reactive protein to featur of the metabolic syndrome in normal glucose tolerant,impaired glucose tolerant,and newly diagnosed type 2 diabetic subjects.Diabetes Metab,2003;29(1):65～71.
4Pradhan AD,Manson JE,Rifai N,et al.C-reactive protein,interleukin 6,and risk of developing type 2 diabetes mellitus. JAMA, 2001,18;286(3):327～334.
5Shikano M,Sobajima H,Yoshikawa H,et al.Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy.Nephron.2000;85(1):81～85.
6Otto C,Engelschalk C,Fraunberger P,et al.Lack of an association of urinary albumin excretion with interleukin-6 or C-reactive protein in patients with type 2 diabetes.Acta Diabetol,2001,38(4):153～155.
7Festa A,D′Agostino R Jr,Tracy RP,et al.Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes:the insulin resistance atheroscler-osis study.Diabetes,2002,51(4):1131～1137.
8Wong TY,Poon P,Szeto CC,et al.Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.Kidney Int,2000,57(2):632～638.
9Fogari R,Mugellini A,Zoppi A,et al.Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients.Am J Hypertens,2002,15;(4 Pt 1):316～320.
9Luo JL,Kamata H,Karin M.IKK/NFκB signaling:balancing life and death-a new approach to cancer therapy[J].The Journal of Clinical Investi-gation,2005,115(10):2625-2632.
10Perkins ND.Integrating cell-signaling pathways with NF-κB and IKK function[J].Nature,2007,8(1):49-62.
